IMC Chicago
BNTX icon

IMC Chicago’s BioNTech BNTX Stock Holding History

IMC Chicago’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Sell
125,700
-23,900
-16% -$2.25M ﹤0.01% 1432
2026
Q1 		$13.3M Buy
149,600
+42,800
+40% +$4.4M ﹤0.01% 1079
2025
Q4 		$10.2M Sell
106,800
-30,500
-22% -$3.07M ﹤0.01% 1210
2025
Q3 		$13.5M Buy
137,300
+21,600
+19% +$2.31M ﹤0.01% 985
2025
Q2 		$12.3M Sell
115,700
-30,400
-21% -$3.07M 0.01% 931
2025
Q1 		$13.3M Buy
146,100
+31,500
+27% +$3.53M 0.01% 754
2024
Q4 		$13.1M Sell
114,600
-18,200
-14% -$2.08M 0.01% 787
2024
Q3 		$15.8M Buy
132,800
+9,800
+8% +$901K 0.01% 636
2024
Q2 		$9.88M Buy
123,000
+1,600
+1% +$146K 0.01% 792
2024
Q1 		$11.2M Buy
121,400
+23,700
+24% +$2.27M 0.01% 665
2023
Q4 		$10.3M Buy
97,700
+24,800
+34% +$2.5M 0.01% 636
2023
Q3 		$7.92M Buy
72,900
+8,100
+13% +$896K 0.01% 617
2023
Q2 		$6.99M Buy
64,800
+3,300
+5% +$371K 0.01% 585
2023
Q1 		$7.66M Sell
61,500
-24,200
-28% -$3.32M 0.01% 559
2022
Q4 		$12.9M Sell
85,700
-10,900
-11% -$1.68M 0.02% 404
2022
Q3 		$13M Sell
96,600
-62,100
-39% -$9.49M 0.02% 388
2022
Q2 		$23.7M Sell
158,700
-18,800
-11% -$2.87M 0.03% 252
2022
Q1 		$30.3M Buy
177,500
+6,400
+4% +$1.08M 0.03% 262
2021
Q4 		$44.1M Sell
171,100
-83,300
-33% -$22.8M 0.04% 228
2021
Q3 		$69.4M Buy
254,400
+199,600
+364% +$63.4M 0.07% 132
2021
Q2 		$12.3M Sell
54,800
-59,900
-52% -$11.3M 0.02% 417
2021
Q1 		$12.5M Buy
114,700
+53,200
+87% +$5.65M 0.02% 394
2020
Q4 		$5.01M Buy
+61,500
New +$6.04M 0.01% 546

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

IMC Chicago's BNTX Position: Q2 2026 in Review

IMC Chicago increased its BioNTech (BNTX) stake by 6.2% in Q2 2026, buying an estimated $161K and bringing the position to 29,282 shares worth $2.72M. The position accounts for ﹤0.01% of the portfolio, ranked #2721.

IMC Chicago first reported a position in BNTX in Q3 2021 and has held it in 13 quarters since. The position peaked at $7.35M in Q3 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • IMC Chicago held 29,282 shares of BioNTech worth $2.72M as of Q2 2026.
  • IMC Chicago bought 1,711 BioNTech shares in Q2 2026, an estimated $161K.
  • BioNTech made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #2721 holding.
  • IMC Chicago first reported a position in BioNTech in Q3 2021 and has held it in 13 quarters since.
  • IMC Chicago's BioNTech position peaked at $7.35M in Q3 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.